日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Robust Immunohistochemistry-Based Classification for BRAF V600E-Mutant Colorectal Cancer With Clinical Implications.

基于免疫组织化学的BRAF V600E突变型结直肠癌的稳健分类及其临床意义。

Liu Chao, Ruan Yuli, Wu Tong, Luan Xindi, Ma Yue, Wang Hong, Dang Tianjiao, Ou Yiwen, Wang Bojun, Zhang Chunhui, Meng Hongxue, Zhang Yanqiao

IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses

IL-17A阻断可减轻免疫检查点抑制剂相关的银屑病样皮疹:临床前和临床反应

Ruan, Yuli; Shi, Mengde; Ma, Yue; Wang, Bojun; Ma, Ming; Dang, Tianjiao; Zhang, Yanqiao; Liu, Chao

Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.

肿瘤侵袭防御指数——预测 II-III 期结直肠癌复发和生存的新指标

Wu Tong, Fang Lin, Ruan Yuli, Shi Mengde, Su Dan, Ma Yue, Ma Ming, Wang Bojun, Liao Yuanyu, Han Shuling, Lu Xiaolin, Zhang Chunhui, Liu Chao, Zhang Yanqiao

Molecular Subtyping and Genomic Profiling Expand Precision Medicine in KRAS Wild-Type Pancreatic Cancer

分子分型和基因组分析拓展了KRAS野生型胰腺癌的精准医疗

Su, Dan; Ruan, Yuli; Shi, Yingfei; Cao, Dandan; Wu, Tong; Dang, Tianjiao; Wang, Hong; Xin, Yaqun; Ma, Ming; Meng, Hongxue; Liu, Chao; Zhang, Yanqiao

VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage

VDR通过激活CCL20介导的肿瘤相关巨噬细胞M2极化,在体内促进胰腺癌的进展。

Li, Hengzhen; Ruan, Yuli; Liu, Chao; Fan, Xiaona; Yao, Yuanfei; Dai, Yisheng; Song, Yushuai; Jiang, Dan; Sun, Ning; Jiao, Guangtao; Chen, Zhuo; Fan, Shiheng; Meng, Fanfei; Yang, Huike; Zhang, Yanqiao; Li, Zhiwei

Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma

动态放射学特征可预测食管鳞状细胞癌新辅助免疫化疗后的病理反应

Ruan, Yuli; Ma, Yue; Ma, Ming; Liu, Chao; Su, Dan; Guan, Xin; Yang, Rui; Wang, Hong; Li, Tianqin; Zhou, Yang; Ma, Jianqun; Zhang, Yanqiao

Epigenetics and immunotherapy in colorectal cancer: progress and promise

表观遗传学和免疫疗法在结直肠癌中的应用:进展与前景

Dang, Tianjiao; Guan, Xin; Cui, Luying; Ruan, Yuli; Chen, Zhuo; Zou, Haoyi; Lan, Ya; Liu, Chao; Zhang, Yanqiao

Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma

回顾性研究TP和PF方案联合或不联合免疫检查点抑制剂一线治疗局部晚期或晚期食管鳞状细胞癌的疗效

Zhang, Zhengfeng; Yang, Lei; Wang, Dazhen; Ruan, Yuli; Zhang, Jianji; Zhao, Lu; Yang, Liu; Lou, Changjie

Advances and prospects of drug clinical research in colorectal cancer in 2022

2022年结直肠癌药物临床研究的进展与展望

Su, Dan; Liu, Chao; Cui, Jie; Tang, Jiebing; Ruan, Yuli; Zhang, Yanqiao